NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East

A Tender Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Framework (Products)
Duration
2 year
Value
£442M
Sector
HEALTH
Published
30 Apr 2021
Delivery
01 Sep 2021 to 31 Aug 2023
Deadline
04 Jun 2021 13:00

Concepts

Location

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

Invitation to offer for NHS Framework Agreement, Branded Medicines for London and South of England. Offer ref number: CM/PHR/20/5598 Lot 01 - LONDON Branded Medicines - Tranche B. Period of Framework 01/09/21 - 31/08/23 with option to extend for a period of 24 months. Lot 02 - LONDON Branded Medicines - Annual Tranche. Period of framework 01/09/21 - 31/08/22 with option to extend for period of 12 months. Lot 03 - SOUTH of England Tranche A. Period of Framework: 01/09/21 - 31/08/23 with option for a period of 24 months Lot 04- SOUTH of England - Tranche B. Period of framework:01/09/21 - 31/08/22 with option to extend for a period of 12 months. Lot 05 - SOUTH of England Annual Tranche. Period of Framework:01/09/21 - 31/08/22 with option to extend for a period of 12 months. Lot 06 - Mids & East and North of England Regions - Bevacizumab. Period of Framework: 01/09/21 - 28/02/22 with option to extend for a period of 6 months.

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Reference

Domains